Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum

A total of 129 symptomatic patients with multiple myeloma (MM) who underwent high‐dose chemotherapy with autologous stem cell transplantation (HDT/ASCT) were analyzed. The 4‐year overall survival (OS) of patients with maintenance (n = 82) was 80%, whereas that of patients without maintenance (n = 47...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakaya, Aya, Shibayama, Hirohiko, Nakatani, Eiji, Shimura, Yuji, Kosugi, Satoru, Tanaka, Hirokazu, Fuchida, Shin‐Ichi, Kanda, Junya, Uoshima, Nobuhiko, Kaneko, Hitomi, Imada, Kazunori, Ohta, Kensuke, Ito, Tomoki, Yagi, Hideo, Yoshihara, Satoshi, Hino, Masayuki, Shimazaki, Chihiro, Takaori‐Kondo, Akifumi, Kuroda, Junya, Matsumura, Itaru, Kanakura, Yuzuru, Nomura, Shosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Haematologic Malignancy ‐ Plasma Cell
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175982/
https://www.ncbi.nlm.nih.gov/pubmed/35845216
http://dx.doi.org/10.1002/jha2.284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175982/
https://www.ncbi.nlm.nih.gov/pubmed/35845216
http://dx.doi.org/10.1002/jha2.284

Ejemplares similares